FIGURE 4.
Expression of F9, TSP-1 and APP in serum exosomes from patients with epilepsy. Western blots demonstrated that (A) exosomal F9 protein was expressed at higher levels in serum from epilepsy patients than healthy controls (n = 25 in each group, ∗P < 0.05); (B) exosomal TSP-1 protein was expressed at lower levels in serum from epilepsy patients than healthy controls (n = 25 in each group, ∗∗P < 0.01); and (C) exosomal APP protein was not significantly different in serum from epilepsy patients than healthy controls (n = 25 in each group). Mean ± SEM Student’s t-test was performed.